Emerging research suggests that Microdosing Semaglutide could reduce neuroinflammation, potentially lowering the risk of Alzheimers and Parkinsons disease
GLP-1 receptors are found throughout the body, including inside the brain, where they are connected to pathways involving reward, stress and impulse control
Phase 3 trials for Retatrutide will eventually provide more extensive human data
Our providers can recommend appropriate supplementation or therapy to restore your energy, support your overall wellness, and help you achieve your health and beauty goals
If insurance covers Wegovy or Zepbound at a low copay, the branded route is usually cheapest
Semaglutide is a GLP-1 receptor agonist that reshapes appetite and metabolism from the brain down